Rapid Virologic Response : A New Milestone in the Management of Chronic Hepatitis CPOORDAD, Fred; RAJENDER REDDY, K; MARTIN, Paul et al.Clinical infectious diseases. 2008, Vol 46, Num 1, pp 78-84, issn 1058-4838, 7 p.Article

Virologic Response Rates of Weight-Based Taribavirin Versus Ribavirin in Treatment-Naive Patients with Genotype 1 Chronic Hepatitis CPOORDAD, Fred; LAWITZ, Eric; SHIFFMAN, Mitchell L et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1208-1215, issn 0270-9139, 8 p.Article

Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin NonrespondersRUSTGI, Vinod K; LEE, William M; MCNAIR, Lindsay et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 6, pp 1719-1726, issn 0270-9139, 8 p.Article

Thrombocytopenia associated with chronic liver diseaseAFDHALL, Nezam; MCHUTCHISON, John; BROWN, Robert et al.Journal of hepatology. 2008, Vol 48, Num 6, pp 1000-1007, issn 0168-8278, 8 p.Article

Refinement of Stopping Rules During Treatment of Hepatitis C Genotype 1 Infection With Boceprevir and Peginterferon/RibavirinJACOBSON, Ira M; MARCELLIN, Patrick; WEIPING DENG et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 2, pp 567-575, issn 0270-9139, 9 p.Article

Boceprevir for Untreated Chronic HCV Genotype 1 InfectionPOORDAD, Fred; MCCONE, Jonathan; DINUBILE, Mark J et al.The New England journal of medicine. 2011, Vol 364, Num 13, pp 1195-1206, issn 0028-4793, 12 p.Article

Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BCHANG, Ting-Tsung; LAI, Ching-Lung; HUI ZHANG et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 2, pp 422-430, issn 0270-9139, 9 p.Article

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1KOWDLEY, Kris V; LAWITZ, Eric; WANGANG XIE et al.The New England journal of medicine. 2014, Vol 370, Num 3, pp 222-232, issn 0028-4793, 11 p.Article

Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patientsSHAYE, Omid A; YADEGARI, Michael; ABREU, Maria T et al.The American journal of gastroenterology. 2007, Vol 102, Num 11, pp 2488-2494, issn 0002-9270, 7 p.Article

Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL StudyMELIA, Michael T; BRÄU, Norbert; SCHIFF, Eugene et al.Clinical infectious diseases. 2014, Vol 58, Num 7, pp 960-969, issn 1058-4838, 10 p.Article

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trialMANNS, Michael; MARCELLIN, Patrick; LENZ, Oliver et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 414-426, issn 0140-6736, 13 p.Article

IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis CLALEZAR, Jacob; BOX, Terry; DUBUC-PATRICK, Gloria et al.Antiviral therapy (London). 2013, Vol 18, Num 6, pp 755-764, issn 1359-6535, 10 p.Article

Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionBACON, Bruce R; GORDON, Stuart C; BURROUGHS, Margaret et al.The New England journal of medicine. 2011, Vol 364, Num 13, pp 1207-1217, issn 0028-4793, 11 p.Article

ABT-450/r―Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisPOORDAD, Fred; HEZODE, Christophe; FORNS, Xavier et al.The New England journal of medicine. 2014, Vol 370, Num 21, pp 1973-1982, issn 0028-4793, 10 p.Article

Retreatment of HCV with ABT-450/r- Ombitasvir and Dasabuvir with RibavirinZEUZEM, Stefan; JACOBSON, Ira M; JENSEN, Donald M et al.The New England journal of medicine. 2014, Vol 370, Num 17, pp 1604-1614, issn 0028-4793, 11 p.Article

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis CPOORDAD, Fred; LAWITZ, Eric; TRIPATHI, Rakesh et al.The New England journal of medicine. 2013, Vol 368, Num 1, pp 45-53, issn 0028-4793, 9 p.Article

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patientsTHOMPSON, Alexander J; CLARK, Paul J; NAGGIE, Susanna et al.Journal of hepatology. 2012, Vol 56, Num 2, pp 313-319, issn 0168-8278, 7 p.Article

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus InfectionSHERMAN, Kenneth E; FLAMM, Steven L; SANKOH, Abdul J et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 1014-1024, issn 0028-4793, 11 p.Article

Rifaximin Treatment in Hepatic EncephalopathyBASS, Nathan M; MULLEN, Kevin D; TEPERMAN, Lewis et al.The New England journal of medicine. 2010, Vol 362, Num 12, pp 1071-1081, issn 0028-4793, 11 p.Article

Morbidity in live liver donors: Standards-based adverse event reporting further refined. Discussion. Invited critiqueSHACKLETON, Christopher R; VIERLING, John M; NISSEN, Nicholas et al.Archives of surgery (Chicago, IL. 1960). 2005, Vol 140, Num 9, pp 888-896, issn 0004-0010, 9 p.Conference Paper

Association of Host Pharmacodynamic Effects with Virologic Response to Pegylated Interferon alfa-2a/ Ribavirin in Chronic Hepatitis CCHUNG, Raymond T; POORDAD, Fred F; HASSANEIN, Tarek et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 6, pp 1906-1914, issn 0270-9139, 9 p.Article

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trialLAWITZ, Éric; POORDAD, Fred F; PANG, Phillip S et al.Lancet (British edition). 2014, Vol 383, Num 9916, pp 515-523, issn 0140-6736, 9 p.Article

Living donor liver transplantation : Histological abnormalities found on liver biopsies of apparently healthy potential donorsIRAN, Tram T; CHANGSRI, Chanikarn; SHACKLETON, C. R et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 2, pp 381-383, issn 0815-9319, 3 p.Article

6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsDUBINSKY, Marla C; VASILIAUSKAS, Eric A; POORDAD, Fred F et al.Gastroenterology (New York, NY. 1943). 2003, Vol 125, Num 2, pp 298-303, issn 0016-5085, 6 p.Article

Retreatment with Telaprevir Combination Therapy in Hepatitis C Patients with Well-Characterized Prior Treatment ResponseMUIR, Andrew J; POORDAD, Fred F; DUSHEIKO, Geoffrey et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 5, pp 1538-1546, issn 0270-9139, 9 p.Article